Xiuyan Wan

2.6k total citations · 1 hit paper
51 papers, 2.4k citations indexed

About

Xiuyan Wan is a scholar working on Materials Chemistry, Inorganic Chemistry and Biomedical Engineering. According to data from OpenAlex, Xiuyan Wan has authored 51 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Materials Chemistry, 22 papers in Inorganic Chemistry and 17 papers in Biomedical Engineering. Recurrent topics in Xiuyan Wan's work include Metal-Organic Frameworks: Synthesis and Applications (21 papers), Nanoplatforms for cancer theranostics (17 papers) and Covalent Organic Framework Applications (11 papers). Xiuyan Wan is often cited by papers focused on Metal-Organic Frameworks: Synthesis and Applications (21 papers), Nanoplatforms for cancer theranostics (17 papers) and Covalent Organic Framework Applications (11 papers). Xiuyan Wan collaborates with scholars based in China and Montenegro. Xiuyan Wan's co-authors include Bo Tang, Na Li, Wei Pan, Zhong Hui, Maochun Hong, Feilong Jiang, Lian Chen, Yuanyuan Chen, Yanhua Li and Yan Yang and has published in prestigious journals such as Angewandte Chemie International Edition, Nano Letters and ACS Nano.

In The Last Decade

Xiuyan Wan

48 papers receiving 2.4k citations

Hit Papers

Tumor-Targeted Cascade Nanoreactor Based on Metal–Organic... 2020 2026 2022 2024 2020 50 100 150 200 250

Peers

Xiuyan Wan
Nem Singh South Korea
Nayoun Won South Korea
Ke Jiang China
C. Michael McGuirk United States
Lu An China
Xiuyan Wan
Citations per year, relative to Xiuyan Wan Xiuyan Wan (= 1×) peers Jiao‐Min Lin

Countries citing papers authored by Xiuyan Wan

Since Specialization
Citations

This map shows the geographic impact of Xiuyan Wan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiuyan Wan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiuyan Wan more than expected).

Fields of papers citing papers by Xiuyan Wan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiuyan Wan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiuyan Wan. The network helps show where Xiuyan Wan may publish in the future.

Co-authorship network of co-authors of Xiuyan Wan

This figure shows the co-authorship network connecting the top 25 collaborators of Xiuyan Wan. A scholar is included among the top collaborators of Xiuyan Wan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiuyan Wan. Xiuyan Wan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Kaiye, Yuting Jia, Xiaohan Liu, et al.. (2025). A hypoxia-activated photothermal agent suppressing thermotolerance and secondary inflammation for enhanced tumor ablation. Chinese Chemical Letters. 111589–111589.
2.
Wan, Xiuyan, et al.. (2025). Logic-gated, triple-responsive DNAzyme nanoplatform for precise hepatocellular carcinoma treatment. Chinese Chemical Letters. 112093–112093.
3.
Wan, Xiuyan, Huiwen Zhang, Wei Pan, et al.. (2025). Metabolic Hijacking: An MOF-Based Nanoprogrammer Overcomes Drug Resistance in Glioblastoma. Nano Letters. 25(34). 12859–12868.
5.
Wan, Xiuyan, et al.. (2025). GalNAc-functionalized metal–organic frameworks for targeted siRNA delivery: enhancing survivin silencing in hepatocellular carcinoma. Biomaterials Science. 13(10). 2704–2712. 4 indexed citations
6.
Wan, Xiuyan, Yu Zhang, Zheng Teng, et al.. (2024). Fe-MOF nanoplatform: Specifically overcoming oxaliplatin resistance in colorectal cancer through multifaceted pathways. Materials Today Nano. 26. 100484–100484. 4 indexed citations
7.
Chen, Jing, Kexin Wang, Xiaodong Zhang, et al.. (2024). Sulfurization-induced lattice disordering in high-entropy catalyst for promoted bifunctional electro-oxidation behavior. Chemical Engineering Journal. 489. 151234–151234. 25 indexed citations
8.
Wang, Dawei, Ping Zhou, Xiuyan Wan, et al.. (2024). A lateral flow assay strip for simultaneous detection of miRNA and exosomes in liver cancer. Chemical Communications. 60(58). 7491–7494. 6 indexed citations
9.
Wan, Xiuyan, Yu Zhang, Huiwen Zhang, et al.. (2024). Cu-MOF-based targeted nanomedicine utilizing biorthogonally catalyzed chemotherapy and chemodynamic therapy with spatiotemporal orchestration to treat hepatocellular carcinoma. Chemical Communications. 61(7). 1415–1418. 1 indexed citations
10.
Zhang, Huiwen, et al.. (2024). Recent advances in spatio-temporally controllable systems for management of glioma. Asian Journal of Pharmaceutical Sciences. 19(5). 100954–100954. 3 indexed citations
11.
Wan, Xiuyan, et al.. (2023). A Covalent Organic Framework Derived N-doped Carbon Nanozyme as the All-rounder for Targeted Catalytic Therapy and NIR-II Photothermal Therapy of Cancer. ACS Applied Materials & Interfaces. 15(38). 44763–44772. 40 indexed citations
12.
Wan, Xiuyan, Qianqian Yan, Hui Hu, et al.. (2022). Sustained-release nanocapsule based on a 3D COF for long-term enzyme prodrug therapy of cancer. Chemical Communications. 58(39). 5877–5880. 21 indexed citations
13.
Gao, Peng, Mengzhen Wang, Yuanyuan Chen, et al.. (2020). A COF-based nanoplatform for highly efficient cancer diagnosis, photodynamic therapy and prognosis. Chemical Science. 11(26). 6882–6888. 115 indexed citations
14.
Chen, Yuanyuan, Zhong Hui, Jianbo Wang, et al.. (2020). Correction: Catalase-like metal–organic framework nanoparticles to enhance radiotherapy in hypoxic cancer and prevent cancer recurrence. Chemical Science. 11(23). 6098–6098. 5 indexed citations
15.
Chen, Yuanyuan, Zhong Hui, Jianbo Wang, et al.. (2019). Catalase-like metal–organic framework nanoparticles to enhance radiotherapy in hypoxic cancer and prevent cancer recurrence. Chemical Science. 10(22). 5773–5778. 147 indexed citations
16.
Wan, Xiuyan, Zhong Hui, Wei Pan, et al.. (2019). Programmed Release of Dihydroartemisinin for Synergistic Cancer Therapy Using a CaCO3 Mineralized Metal–Organic Framework. Angewandte Chemie. 131(40). 14272–14277. 35 indexed citations
17.
Wang, Di, Zhen‐Zhen Xue, Di Zhang, et al.. (2018). The Iodoargentate Framework as a High-Performance “Sweeper” for Specific Dye Pollutant. Crystal Growth & Design. 18(11). 6421–6425. 17 indexed citations
18.
Gai, Yanli, Xueyan Zhao, Yan Chen, et al.. (2018). A cyano-bridged Cu(i)-based organic framework coupled with the C–C bond cleavage of acetonitrile for selective and sensitive sensing of Fe3+ ions. Dalton Transactions. 47(20). 6888–6892. 16 indexed citations
19.
Yang, Yan, Lian Chen, Feilong Jiang, et al.. (2017). A family of doped lanthanide metal–organic frameworks for wide-range temperature sensing and tunable white light emission. Journal of Materials Chemistry C. 5(8). 1981–1989. 136 indexed citations
20.
Xue, Hui, Feilong Jiang, Qihui Chen, et al.. (2015). Conformation driven in situ interlock: from discrete metallocycles to infinite polycatenanes. Chemical Communications. 51(71). 13706–13709. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026